|
GEN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.3001600624184E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.28030003160507E-09 |
| Normal-vs-Stage2 |
1.794890E-04 |
| Normal-vs-Stage3 |
1.00049968310145E-10 |
| Normal-vs-Stage4 |
3.3485999972882E-08 |
| Stage1-vs-Stage2 |
5.397200E-01 |
| Stage1-vs-Stage3 |
2.062000E-02 |
| Stage1-vs-Stage4 |
1.749030E-01 |
| Stage2-vs-Stage3 |
3.966800E-01 |
| Stage2-vs-Stage4 |
7.340600E-01 |
| Stage3-vs-Stage4 |
5.420400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73139280690293E-12 |
| Normal-vs-AfricanAmerican |
2.23539999999467E-05 |
| Normal-vs-Asian |
4.194500E-02 |
| Caucasian-vs-AfricanAmerican |
6.025200E-01 |
| Caucasian-vs-Asian |
8.013500E-02 |
| AfricanAmerican-vs-Asian |
2.181800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99740224360312E-11 |
| Normal-vs-Female |
8.30540081153686E-11 |
| Male-vs-Female |
4.410200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.779280E-03 |
| Normal-vs-Age(41-60Yrs) |
1.7491008641457E-11 |
| Normal-vs-Age(61-80Yrs) |
1.33180022565682E-10 |
| Normal-vs-Age(81-100Yrs) |
1.412150E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.116200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.247000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.647800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.867000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.177000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.127000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.635630E-03 |
| Normal-vs-Grade 2 |
1.92630000839245E-09 |
| Normal-vs-Grade 3 |
9.40725275455634E-12 |
| Normal-vs-Grade 4 |
1.24149999947143E-07 |
| Grade 1-vs-Grade 2 |
9.650800E-01 |
| Grade 1-vs-Grade 3 |
7.363600E-01 |
| Grade 1-vs-Grade 4 |
7.293800E-01 |
| Grade 2-vs-Grade 3 |
4.444600E-01 |
| Grade 2-vs-Grade 4 |
5.670000E-01 |
| Grade 3-vs-Grade 4 |
9.738600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.96589999834629E-08 |
| Normal-vs-ccB subtype |
6.02662364457274E-12 |
| ccA subtype-vs-ccB subtype |
2.349800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.38690170459199E-11 |
| Normal-vs-N1 |
2.104200E-03 |
| N0-vs-N1 |
7.504300E-02 |
|
|
